Ausgabe 3/2024
Inhalt (36 Artikel)
Something still missing in molecular imaging: CXCR2 axis in prostate cancer
Luca Filippi, Laura Evangelista
From pixels to predictions: the scrying power of molecular imaging
Gaia Ninatti, Cristiano Pini, Fabrizia Gelardi, Martina Sollini
Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy
Shiyu Zhu, Beibei Liang, Yuxuan Zhou, Yinfei Chen, Jiayu Fu, Ling Qiu, Jianguo Lin
STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy
Duo Xu, Xin Lu, Fan Yang, Zebo Jiang, Shirui Yang, Lei Bi, Jiani Liu, Hong Shan, Dan Li
Development of a novel 18F-labeled small molecule probe for PET imaging of mesenchymal epithelial transition receptor expression
Lihong Bu, Xiaowei Ma, Aiyan Ji, Kaijun Geng, Hongyan Feng, Li Li, Ao Zhang, Zhen Cheng
Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models
Niels Böhnke, Bård Indrevoll, Stefanie Hammer, Alex Papple, Alexander Kristian, Hans Briem, Arif Celik, Dominik Mumberg, Alan Cuthbertson, Sabine Zitzmann-Kolbe
Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?
H. S. A. Tingen, A. Tubben, J. Bijzet, M. P. van den Berg, P. van der Meer, E. J. Houwerzijl, F. L. H. Muntinghe, P. A. van der Zwaag, A. W. J. M. Glaudemans, M. I. F. J. Oerlemans, C. Knackstedt, M. Michels, A. Hirsch, B. P. C. Hazenberg, R. H. J. A. Slart, H. L. A. Nienhuis
Treatment response assessment in transthyretin-related cardiac amyloidosis: an emerging clinical indication of bone-seeking radiopharmaceuticals?
Olivier Gheysens, Giorgio Treglia, Ahmad Masri, Fabien Hyafil, Sharmila Dorbala
CT attenuation correction improves quantitative risk prediction by cardiac SPECT in obese patients
Attila Feher, Konrad Pieszko, Aakash Shanbhag, Mark Lemley, Bryan Bednarski, Robert J. H. Miller, Cathleen Huang, Leonidas Miras, Yi-Hwa Liu, Albert J. Sinusas, Piotr J. Slomka, Edward J. Miller
Brain perfusion estimation by Tikhonov model-free deconvolution in a long axial field of view PET/CT scanner exploring five different PET tracers
Henrik Bo Wiberg Larsson, Ian Law, Thomas L. Andersen, Flemming L. Andersen, Barbara M. Fischer, Mark B. Vestergaard, Tanne S. W. Larsson, Ulrich Lindberg
Simultaneous high-resolution whole-brain MR spectroscopy and [18F]FDG PET for temporal lobe epilepsy
Hui Huang, Miao Zhang, Yibo Zhao, Yudu Li, Wen Jin, Rong Guo, Wei Liu, Bingyang Cai, Jiwei Li, Siyu Yuan, Xinyun Huang, Xiaozhu Lin, Zhi-Pei Liang, Biao Li, Jie Luo
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
Peter Young, Fiona Heeman, Jan Axelsson, Lyduine E. Collij, Anne Hitzel, Amirhossein Sanaat, Aida Niñerola-Baizan, Andrés Perissinotti, Mark Lubberink, Giovanni B. Frisoni, Habib Zaidi, Frederik Barkhof, Gill Farrar, Suzanne Baker, Juan Domingo Gispert, Valentina Garibotto, Anna Rieckmann, Michael Schöll
Chemokine receptor–targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [18F]FDG
Aleksander Kosmala, Johannes Duell, Simone Schneid, Sebastian E. Serfling, Takahiro Higuchi, Alexander Weich, Constantin Lapa, Philipp E. Hartrampf, Markus Raderer, Hermann Einsele, Andreas K. Buck, Max S. Topp, Wiebke Schlötelburg, Rudolf A. Werner
The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy
Arnoldo Piccardo, Giorgio Treglia, Francesco Fiz, Zvi Bar-Sever, Gianluca Bottoni, Lorenzo Biassoni, Lise Borgwardt, Bart de Keizer, Nina Jehanno, Egesta Lopci, Lars Kurch, Michela Massollo, Helen Nadel, Isabel Roca Bielsa, Barry Shulkin, Reza Vali, Diego De Palma, Diego Cecchin, Ana Isabel Santos, Pietro Zucchetta
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Hanna Berglund, Sara Lundsten Salomonsson, Tabassom Mohajershojai, Fernando Jose Ferrer Gago, David P. Lane, Marika Nestor
Exploring the association of glioma tumor residuals from incongruent [18F]FET PET/MR imaging with tumor proliferation using a multiparametric MRI radiomics nomogram
Xiaoran Li, Ye Cheng, Xin Han, Bixiao Cui, Jing Li, Hongwei Yang, Geng Xu, Qingtang Lin, Xinru Xiao, Jie Tang, Jie Lu
[18F]FET PET/MR and machine learning in the evaluation of glioma
Leandra Piscopo, Emilia Zampella, Michele Klain
PET/CT imaging with radiolabeled FAPI: new opportunities for diagnosis and treatment of thyroid cancer
Leandra Piscopo, Fabio Volpe
Letter to the Editor: Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
Fernanda Miyuki Sasaki, Aline Lopes Garcia Leal, Paulo José de Almeida Filho, Felipe Alves Mourato
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
Madhav P. Yadav, Sanjana Ballal, Marcel Martin, Frank Roesch, Swayamjeet Satapathy, Euy S. Moon, Madhavi Tripathi, Ajay Gogia, Chandrasekhar Bal
The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy
H. Siebinga, J. J. M. A. Hendrikx, D. M. V. de Vries-Huizing, A. D. R. Huitema, B. J. de Wit-van der Veen
The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
Duygu Has Simsek, Yunus Guzel, Dilara Denizmen, Yasemin Sanli, Fikret Buyukkaya, Bilal Kovan, Halil Komek, Emine Goknur Isik, Zeynep Gozde Ozkan, Serkan Kuyumcu
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
Manuel Weber, Olof Pettersson, Robert Seifert, Benedikt M. Schaarschmidt, Wolfgang P. Fendler, Christoph Rischpler, Harald Lahner, Ken Herrmann, Anders Sundin
The role of [68 Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study
Caner Civan, Serkan Kuyumcu, Duygu Has Simsek, Oner Sanli, Emine Goknur Isik, Zeynep Gozde Ozkan, Ozge Hurdogan, Yasemin Sanli
FAPI PET/CT: a new kid on the block for RCC
Cristian Udovicich, Marlon Perera, Michael S. Hofman, Shankar Siva
The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients
Matteo Bauckneht, Enrico Checcucci, Edoardo Cisero, Alessio Rizzo, Manuela Racca, Sabrina De Cillis, Daniele Amparore, Stefano De Luca, Cristian Fiori, Pasquale Rescigno, Francesco Porpiglia
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer
Jie Zang, Guochang Wang, Tianzhi Zhao, Huipan Liu, Xiuting Lin, Yun Yang, Zezhong Shao, Chao Wang, Haojun Chen, Yue Chen, Zhaohui Zhu, Weibing Miao, Xiaoyuan Chen, Jingjing Zhang
Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule
Davide Bianco, Carmela Nappi, Michele Klain
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry
Caroline Burgard, Connor Hein, Arne Blickle, Mark Bartholomä, Stephan Maus, Sven Petto, Andrea Schaefer-Schuler, Samer Ezziddin, Florian Rosar
Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [68Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [68Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs
Ruohua Chen, Yee Ling Ng, Xinlan Yang, Yinjie Zhu, Lianghua Li, Haitao Zhao, Gang Huang, Jianjun Liu
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial
Samuele Ghezzo, Paola Mapelli, Ana Maria Samanes Gajate, Anna Palmisano, Vito Cucchiara, Giorgio Brembilla, Carolina Bezzi, Nazareno Suardi, Paola Scifo, Alberto Briganti, Francesco De Cobelli, Arturo Chiti, Antonio Esposito, Maria Picchio
A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [68Ga]Ga-PSMA-11 total-body PET/CT imaging
Jing Lv, Haojun Yu, Hongyan Yin, Yimeng Shi, Hongcheng Shi
Pigmented villonodular synovitis detected by [68Ga]Ga-FAPI-04 PET/CT
Chunmei Guo, Lingzhi Li, Dengsai Peng, Feiyu Zhang, Zhanwen Huang
Epithelioid granuloma mimicking lung cancer showed intense uptake on [18F]FAPI-74 PET
Tadashi Watabe, Ivan Ray David, Toru Kimura, Takashi Hiroshima, Mitsuaki Tatsumi, Sadahiro Naka, Takashi Kamiya, Eriko Fukui, Takashi Kanou, Naoko Ose, Soichiro Funaki, Yuriko Mori, Jens Cardinale, Hiroki Kato, Eiichi Morii, Yasushi Shintani, Frederik L. Giesel